USE OF PEPTIDES IN TRACING DISEASE AND DEVELOPING VACCINES

摘要

This process invention involves using small peptide fragments (9-50 amino acids in length) in a delayed-type hypersensitivity (DTH) assay to determine, in vivo in humans, the T-lymphocyte epitopes of a large antigen.